First time human-on-a-chip predicts in vivo results based on in vitro model

Hesperos Inc., pioneers of the "human-on-a-chip" in vitro system has announced the use of its innovative multi-organ model to successfully measure the concentration and metabolism of two known cardiotoxic small molecules over time, to accurately describe the drug behavior and toxic effects in vivo. The findings further support the potential of body-on-a-chip systems to transform the drug discovery process.

source https://www.lifetechnology.com/blogs/life-technology-news-blog/first-time-human-on-a-chip-predicts-in-vivo-results-based-on-in-vitro-model